TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD)

CUSIP: 88338N206

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
11,549,491
Total 13F shares
3,384,889
Share change
+81,101
Total reported value
$5,517,397
Price per share
$1.63
Number of holders
41
Value change
+$146,413
Number of buys
11
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 88338N206?
CUSIP 88338N206 identifies TXMD - TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) as of Q4 2025

As of 31 Dec 2025, TherapeuticsMD, Inc. - Common Stock, par value $0.001 per share (TXMD) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 3,384,889 shares. The largest 10 holders included Rubric Capital Management LP, Clearline Capital LP, VANGUARD GROUP INC, Tejara Capital Ltd, ADAR1 Capital Management, LLC, MORGAN STANLEY, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP. This page lists 41 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.